Method of treating neurodegenerative disorders of the retina and optic nerve head
US6638976B2 · kind B2 · utility
6Cited by
22References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 13, 2001 |
| Grant date | Oct 28, 2003 |
| Priority date | — |
| Expiry date | Aug 13, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The use of 3-benzolphenylacetic acids and derivatives, including nepafenac, to treat neurodegenerative retinal disorders is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.